Y0001555
Ciclesonide impurity B
European Pharmacopoeia (EP) Reference Standard
别名:
Desisobutyryl-ciclesonide, (2′R)-2′-Cyclohexyl-11b,21-dihydroxy-16bH-[1,3]dioxolo[4′,5′:16,17]pregna-1,4-diene-3,20-dione
生物来源
synthetic
等级
pharmaceutical primary standard
Agency
EP
API类
ciclesonide
表单
powder
包装
pkg of 10 mg
制造商/商品名称
EDQM
储存条件
protect from light
溶解性
water: <0.1 g/L
应用
pharmaceutical (small molecule)
包装形式
neat
运输
ambient
储存温度
2-8°C
SMILES字符串
O1[C@@]2([C@H](O[C@H]1C6CCCCC6)C[C@@H]3[C@@]2(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@@]54C)O)C)C(=O)CO
InChI
1S/C28H38O6/c1-26-11-10-18(30)12-17(26)8-9-19-20-13-23-28(22(32)15-29,27(20,2)14-21(31)24(19)26)34-25(33-23)16-6-4-3-5-7-16/h10-12,16,19-21,23-25,29,31H,3-9,13-15H2,1-2H3/t19-,20-,21-,23+,24+,25+,26-,27-,28+/m0/s1
InChI key
OXPLANUPKBHPMS-ZXBNPROVSA-N
一般描述
Ciclesonide impurity B is an impurity of ciclesonide, a new-generation, non-halogenated glucocorticoid.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
应用
Ciclesonide impurity B is used as an EP reference standard to quantify the analyte in pharmaceutical formulations by liquid chromatography (LC) technique.
包装
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
其他说明
Sales restrictions may apply.
法规信息
新产品
此项目有
New Drugs for Asthma, Allergy and COPD, 42, 42-54 (2001)
Ciclesonide
European Pharmacopoeia Commission and European Directorate for the Quality of Medicines & Healthcare
European pharmacopoeia, 43, 2206-2207 (2017)
Rethinking Cleaning Validation for API Manufacturing
Zhang C, et al.
Pharmaceutical Technology, 42, 42-54 (2018)
Pharmacokinetics of [14 C] ciclesonide after oral and intravenous administration to healthy subjects
Nave R, et al.
Clinical Pharmacokinetics, 43, 479-486 (2004)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持